Wearable ballistocardiogram and seismocardiogram systems for health and performance

Autor: Etemadi, Mozziyar; Inan, Omer T.
Sprache: Englisch
Veröffentlicht: 2018
Quelle: PubMed Central (PMC)
Online Zugang: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867366/
http://www.ncbi.nlm.nih.gov/pubmed/28798198
http://dx.doi.org/10.1152/japplphysiol.00298.2017
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867366/
https://doi.org/10.1152/japplphysiol.00298.2017
Erfassungsnummer: ftpubmed:oai:pubmedcentral.nih.gov:5867366

Zusammenfassung

Cardiovascular diseases (CVDs) are prevalent in the US, and many forms of CVD primarily affect the mechanical aspects of heart function. Wearable technologies for monitoring the mechanical health of the heart and vasculature could enable proactive management of CVDs through titration of care based on physiological status as well as preventative wellness monitoring to help promote lifestyle choices that reduce the overall risk of developing CVDs. Additionally, such wearable technologies could be used to optimize human performance in austere environments. This review describes our progress in developing wearable ballistocardiogram (BCG)- and seismocardiogram-based systems for monitoring relative changes in cardiac output, contractility, and blood pressure. Our systems use miniature, low-noise accelerometers to measure the movements of the body in response to the heartbeat and novel machine learning algorithms to provide robustness against motion artifacts and sensor misplacement. Moreover, we have mathematically related wearable BCG signals—representing local, cardiogenic movements of a point on the body—to better understood whole body BCG signals, and thereby improved estimation of key health parameters. We validated these systems with experiments in healthy subjects, studies in patients with heart failure, and measurements in austere environments such as water immersion. The systems can be used in future work as a tool for clinicians and physiologists to measure the mechanical aspects of cardiovascular function outside of clinical settings, and to thereby titrate care for patients with CVDs, provide preventative screening, and optimize performance in austere environments by providing real-time in-depth information regarding performance and risk.